<DOC>
	<DOCNO>NCT00020579</DOCNO>
	<brief_summary>RATIONALE : MS-275 may stop growth cancer cell block enzymes necessary growth . PURPOSE : This phase I trial study side effect best dose MS-275 treating patient advance solid tumor lymphoma .</brief_summary>
	<brief_title>MS-275 Treating Patients With Advanced Solid Tumors Lymphoma</brief_title>
	<detailed_description>OBJECTIVES : - Determine dose-limiting toxicity maximum tolerate dose MS-275 patient advance solid tumor lymphomas . - Determine profile adverse event , include change laboratory parameter , patient treat drug . - Assess pharmacology pharmacokinetics drug patient . - Design MS-275 regimen possibly frequent dose administration base pharmacology MS-275 use schedule study . - Determine antineoplastic activity drug patient . OUTLINE : This open-label , dose-escalation study . Patients receive oral MS-275 day 1 . Courses repeat every 2 week ( every 2-week schedule ) . Alternatively , patient receive oral MS-275 day 1 , 8 , 15 , 22 ( weekly schedule ) . Courses repeat every 6 week . Treatment schedule continue absence disease progression unacceptable toxicity . Cohorts 3-6 patient receive escalate dos MS-275 every 2-week schedule maximum tolerate dose ( MTD ) determine . Once MTD every 2-week schedule determine , patient receive treatment weekly schedule . The MTD determine weekly schedule . The MTD schedule define dose precede least 2 6 patient experience dose-limiting toxicity . Once MTD determine weekly schedule , 3 additional patient accrue receive MS-275 MTD weekly schedule . Disease status assess every 3 month . PROJECTED ACCRUAL : A total 50-75 patient accrue study .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Histone Deacetylase Inhibitors</mesh_term>
	<mesh_term>Entinostat</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm malignancy metastatic unresectable effective standard curative palliative therapy exist Brain metastasis allow provide follow criterion meet : Received treatment brain metastasis Stable ≥ 6 month without steroid antiseizure medication PATIENT CHARACTERISTICS : Age : 18 Performance status : ECOG 02 OR Karnofsky 50100 % Life expectancy : More 3 month Hematopoietic : WBC least 3,000/mm^3 Absolute neutrophil count least 1,500/mm^3 Platelet count least 100,000/mm^3 Hepatic : Bilirubin great 1.5 time upper limit normal ( ULN ) ( ≤ 3 mg/dL patient Gilbert 's syndrome ) AST/ALT great 2.5 time ULN Albumin least 75 % low limit normal Renal : Creatinine normal OR Creatinine clearance least 60 mL/min Cardiovascular : Cardiac ejection fraction normal MUGA No symptomatic congestive heart failure No unstable angina pectoris No cardiac arrhythmia Other : Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception Adequate oral intake No weight loss 10 % actual body weight within past 2 month No history allergic reaction compound similar chemical biological composition study drug No uncontrolled illness No ongoing active infection No seizure disorder No psychiatric illness social situation would preclude study compliance No acute chronic gastrointestinal condition ( e.g. , peptic ulcer colitis ) within past 2 month would interfere drug tolerance absorption Willing able selfadminister document dose MS275 PRIOR CONCURRENT THERAPY : Biologic therapy : At least 4 week since prior anticancer vaccine therapy recover No concurrent immunotherapy Chemotherapy : At least 4 week since prior anticancer chemotherapy ( 6 week nitrosoureas mitomycin ) recover At least 8 week since prior UCN01 recover No concurrent chemotherapy Endocrine therapy : At least 4 week since prior anticancer hormonal therapy ( except gonadotropinreleasing hormone [ GnRH ] agonist ) recover Concurrent corticosteroid physiological replacement , antiemetic therapy , ongoing condition allow Must stable dose past 4 week No concurrent anticancer hormonal therapy except GnRH agonist noncastrated patient prostate cancer Radiotherapy : At least 4 week since prior anticancer radiotherapy recover No concurrent radiotherapy Concurrent localize radiotherapy single lesion allow patient achieves least partial response Surgery : At least 3 week since prior major surgery Other : No concurrent investigational commercial antineoplastic therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>stage IV cutaneous T-cell non-Hodgkin lymphoma</keyword>
	<keyword>recurrent cutaneous T-cell non-Hodgkin lymphoma</keyword>
	<keyword>small intestine lymphoma</keyword>
	<keyword>stage IV grade 1 follicular lymphoma</keyword>
	<keyword>stage IV grade 2 follicular lymphoma</keyword>
	<keyword>stage IV grade 3 follicular lymphoma</keyword>
	<keyword>stage IV adult diffuse small cleave cell lymphoma</keyword>
	<keyword>stage IV adult diffuse mixed cell lymphoma</keyword>
	<keyword>stage IV adult diffuse large cell lymphoma</keyword>
	<keyword>stage IV adult immunoblastic large cell lymphoma</keyword>
	<keyword>stage IV adult lymphoblastic lymphoma</keyword>
	<keyword>stage IV adult Burkitt lymphoma</keyword>
	<keyword>recurrent grade 1 follicular lymphoma</keyword>
	<keyword>recurrent grade 2 follicular lymphoma</keyword>
	<keyword>recurrent grade 3 follicular lymphoma</keyword>
	<keyword>recurrent adult diffuse small cleave cell lymphoma</keyword>
	<keyword>recurrent adult diffuse mixed cell lymphoma</keyword>
	<keyword>recurrent adult diffuse large cell lymphoma</keyword>
	<keyword>recurrent adult immunoblastic large cell lymphoma</keyword>
	<keyword>recurrent adult lymphoblastic lymphoma</keyword>
	<keyword>recurrent adult Burkitt lymphoma</keyword>
	<keyword>stage IV adult T-cell leukemia/lymphoma</keyword>
	<keyword>recurrent adult T-cell leukemia/lymphoma</keyword>
	<keyword>primary central nervous system non-Hodgkin lymphoma</keyword>
	<keyword>intraocular lymphoma</keyword>
	<keyword>stage IV mantle cell lymphoma</keyword>
	<keyword>recurrent mantle cell lymphoma</keyword>
	<keyword>angioimmunoblastic T-cell lymphoma</keyword>
	<keyword>anaplastic large cell lymphoma</keyword>
	<keyword>stage IV mycosis fungoides/Sezary syndrome</keyword>
	<keyword>recurrent mycosis fungoides/Sezary syndrome</keyword>
	<keyword>recurrent marginal zone lymphoma</keyword>
	<keyword>recurrent small lymphocytic lymphoma</keyword>
	<keyword>stage IV small lymphocytic lymphoma</keyword>
	<keyword>stage IV marginal zone lymphoma</keyword>
	<keyword>extranodal marginal zone B-cell lymphoma mucosa-associated lymphoid tissue</keyword>
	<keyword>nodal marginal zone B-cell lymphoma</keyword>
	<keyword>splenic marginal zone lymphoma</keyword>
	<keyword>male breast cancer</keyword>
	<keyword>stage IIIA breast cancer</keyword>
	<keyword>stage IIIB breast cancer</keyword>
	<keyword>stage IIIC breast cancer</keyword>
	<keyword>stage IV breast cancer</keyword>
	<keyword>recurrent pancreatic cancer</keyword>
	<keyword>stage III pancreatic cancer</keyword>
	<keyword>recurrent colon cancer</keyword>
	<keyword>stage III colon cancer</keyword>
	<keyword>stage IV colon cancer</keyword>
	<keyword>recurrent rectal cancer</keyword>
	<keyword>stage III rectal cancer</keyword>
	<keyword>stage IV rectal cancer</keyword>
	<keyword>recurrent ovarian epithelial cancer</keyword>
	<keyword>recurrent ovarian germ cell tumor</keyword>
	<keyword>stage III ovarian epithelial cancer</keyword>
	<keyword>stage III ovarian germ cell tumor</keyword>
	<keyword>stage IV ovarian epithelial cancer</keyword>
	<keyword>stage IV ovarian germ cell tumor</keyword>
	<keyword>recurrent malignant testicular germ cell tumor</keyword>
	<keyword>stage III malignant testicular germ cell tumor</keyword>
	<keyword>recurrent cervical cancer</keyword>
	<keyword>stage III cervical cancer</keyword>
	<keyword>stage IVA cervical cancer</keyword>
	<keyword>stage IVB cervical cancer</keyword>
	<keyword>recurrent endometrial carcinoma</keyword>
	<keyword>stage III endometrial carcinoma</keyword>
	<keyword>stage IV endometrial carcinoma</keyword>
	<keyword>fallopian tube cancer</keyword>
	<keyword>primary peritoneal cavity cancer</keyword>
	<keyword>recurrent uterine sarcoma</keyword>
	<keyword>stage III uterine sarcoma</keyword>
	<keyword>stage IV uterine sarcoma</keyword>
	<keyword>recurrent vaginal cancer</keyword>
	<keyword>stage III vaginal cancer</keyword>
	<keyword>stage IVA vaginal cancer</keyword>
	<keyword>stage IVB vaginal cancer</keyword>
	<keyword>recurrent vulvar cancer</keyword>
	<keyword>stage III vulvar cancer</keyword>
	<keyword>stage IV vulvar cancer</keyword>
	<keyword>recurrent anal cancer</keyword>
	<keyword>stage IIIA anal cancer</keyword>
	<keyword>stage IIIB anal cancer</keyword>
	<keyword>stage IV anal cancer</keyword>
	<keyword>recurrent esophageal cancer</keyword>
	<keyword>stage III esophageal cancer</keyword>
	<keyword>stage IV esophageal cancer</keyword>
	<keyword>recurrent gastric cancer</keyword>
	<keyword>stage III gastric cancer</keyword>
	<keyword>stage IV gastric cancer</keyword>
	<keyword>recurrent extrahepatic bile duct cancer</keyword>
	<keyword>unresectable extrahepatic bile duct cancer</keyword>
	<keyword>advanced adult primary liver cancer</keyword>
	<keyword>localize unresectable adult primary liver cancer</keyword>
	<keyword>recurrent adult primary liver cancer</keyword>
	<keyword>recurrent squamous cell carcinoma larynx</keyword>
	<keyword>recurrent verrucous carcinoma larynx</keyword>
	<keyword>stage III squamous cell carcinoma larynx</keyword>
	<keyword>stage III verrucous carcinoma larynx</keyword>
	<keyword>stage IV squamous cell carcinoma larynx</keyword>
	<keyword>stage IV verrucous carcinoma larynx</keyword>
	<keyword>recurrent basal cell carcinoma lip</keyword>
	<keyword>recurrent squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage III basal cell carcinoma lip</keyword>
	<keyword>stage III squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage IV basal cell carcinoma lip</keyword>
	<keyword>stage IV squamous cell carcinoma lip oral cavity</keyword>
	<keyword>recurrent lymphoepithelioma oropharynx</keyword>
	<keyword>recurrent squamous cell carcinoma oropharynx</keyword>
	<keyword>stage III lymphoepithelioma oropharynx</keyword>
	<keyword>stage III squamous cell carcinoma oropharynx</keyword>
	<keyword>stage IV lymphoepithelioma oropharynx</keyword>
	<keyword>stage IV squamous cell carcinoma oropharynx</keyword>
	<keyword>recurrent lymphoepithelioma nasopharynx</keyword>
	<keyword>recurrent squamous cell carcinoma nasopharynx</keyword>
	<keyword>stage III lymphoepithelioma nasopharynx</keyword>
	<keyword>stage III squamous cell carcinoma nasopharynx</keyword>
	<keyword>stage IV lymphoepithelioma nasopharynx</keyword>
	<keyword>stage IV squamous cell carcinoma nasopharynx</keyword>
	<keyword>recurrent esthesioneuroblastoma paranasal sinus nasal cavity</keyword>
	<keyword>recurrent invert papilloma paranasal sinus nasal cavity</keyword>
	<keyword>recurrent midline lethal granuloma paranasal sinus nasal cavity</keyword>
	<keyword>recurrent squamous cell carcinoma paranasal sinus nasal cavity</keyword>
	<keyword>stage III esthesioneuroblastoma paranasal sinus nasal cavity</keyword>
	<keyword>stage III invert papilloma paranasal sinus nasal cavity</keyword>
	<keyword>stage III midline lethal granuloma paranasal sinus nasal cavity</keyword>
	<keyword>stage III squamous cell carcinoma paranasal sinus nasal cavity</keyword>
	<keyword>stage IV esthesioneuroblastoma paranasal sinus nasal cavity</keyword>
	<keyword>stage IV invert papilloma paranasal sinus nasal cavity</keyword>
	<keyword>stage IV midline lethal granuloma paranasal sinus nasal cavity</keyword>
	<keyword>stage IV squamous cell carcinoma paranasal sinus nasal cavity</keyword>
	<keyword>metastatic parathyroid cancer</keyword>
	<keyword>recurrent parathyroid cancer</keyword>
	<keyword>recurrent salivary gland cancer</keyword>
	<keyword>stage III salivary gland cancer</keyword>
	<keyword>stage IV salivary gland cancer</keyword>
	<keyword>recurrent bladder cancer</keyword>
	<keyword>recurrent gallbladder cancer</keyword>
	<keyword>stage III bladder cancer</keyword>
	<keyword>stage IV bladder cancer</keyword>
	<keyword>unresectable gallbladder cancer</keyword>
	<keyword>recurrent renal cell cancer</keyword>
	<keyword>stage III renal cell cancer</keyword>
	<keyword>stage IV renal cell cancer</keyword>
	<keyword>stage III Wilms tumor</keyword>
	<keyword>stage IV Wilms tumor</keyword>
	<keyword>stage V Wilms tumor</keyword>
	<keyword>metastatic transitional cell cancer renal pelvis ureter</keyword>
	<keyword>recurrent transitional cell cancer renal pelvis ureter</keyword>
	<keyword>regional transitional cell cancer renal pelvis ureter</keyword>
	<keyword>anterior urethral cancer</keyword>
	<keyword>posterior urethral cancer</keyword>
	<keyword>recurrent urethral cancer</keyword>
	<keyword>recurrent penile cancer</keyword>
	<keyword>stage III penile cancer</keyword>
	<keyword>stage IV penile cancer</keyword>
	<keyword>recurrent prostate cancer</keyword>
	<keyword>stage III prostate cancer</keyword>
	<keyword>stage IV prostate cancer</keyword>
	<keyword>metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor</keyword>
	<keyword>recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor</keyword>
	<keyword>metastatic osteosarcoma</keyword>
	<keyword>recurrent osteosarcoma</keyword>
	<keyword>recurrent adult soft tissue sarcoma</keyword>
	<keyword>stage III adult soft tissue sarcoma</keyword>
	<keyword>stage IV adult soft tissue sarcoma</keyword>
	<keyword>classic Kaposi sarcoma</keyword>
	<keyword>AIDS-related Kaposi sarcoma</keyword>
	<keyword>recurrent Kaposi sarcoma</keyword>
	<keyword>stage III cutaneous T-cell non-Hodgkin lymphoma</keyword>
	<keyword>ciliary body choroid melanoma , medium/large size</keyword>
	<keyword>ciliary body choroid melanoma , small size</keyword>
	<keyword>extraocular extension melanoma</keyword>
	<keyword>iris melanoma</keyword>
	<keyword>recurrent intraocular melanoma</keyword>
	<keyword>recurrent melanoma</keyword>
	<keyword>stage III melanoma</keyword>
	<keyword>stage IV melanoma</keyword>
	<keyword>extensive stage small cell lung cancer</keyword>
	<keyword>recurrent non-small cell lung cancer</keyword>
	<keyword>recurrent small cell lung cancer</keyword>
	<keyword>stage IIIA non-small cell lung cancer</keyword>
	<keyword>stage IIIB non-small cell lung cancer</keyword>
	<keyword>stage IV non-small cell lung cancer</keyword>
	<keyword>recurrent thymoma thymic carcinoma</keyword>
	<keyword>advanced malignant mesothelioma</keyword>
	<keyword>recurrent malignant mesothelioma</keyword>
	<keyword>recurrent adrenocortical carcinoma</keyword>
	<keyword>stage III adrenocortical carcinoma</keyword>
	<keyword>stage IV adrenocortical carcinoma</keyword>
	<keyword>metastatic gastrointestinal carcinoid tumor</keyword>
	<keyword>recurrent gastrointestinal carcinoid tumor</keyword>
	<keyword>regional gastrointestinal carcinoid tumor</keyword>
	<keyword>desmoid tumor</keyword>
	<keyword>newly diagnose carcinoma unknown primary</keyword>
	<keyword>recurrent carcinoma unknown primary</keyword>
	<keyword>undifferentiated carcinoma unknown primary</keyword>
	<keyword>carcinoma appendix</keyword>
	<keyword>recurrent metastatic squamous neck cancer occult primary</keyword>
	<keyword>untreated metastatic squamous neck cancer occult primary</keyword>
	<keyword>recurrent pituitary tumor</keyword>
	<keyword>adult anaplastic astrocytoma</keyword>
	<keyword>adult astrocytic tumor</keyword>
	<keyword>adult diffuse astrocytoma</keyword>
	<keyword>adult pilocytic astrocytoma</keyword>
	<keyword>adult anaplastic oligodendroglioma</keyword>
	<keyword>adult brain stem glioma</keyword>
	<keyword>adult oligodendroglioma</keyword>
	<keyword>adult mixed glioma</keyword>
	<keyword>adult central nervous system germ cell tumor</keyword>
	<keyword>adult choroid plexus tumor</keyword>
	<keyword>adult craniopharyngioma</keyword>
	<keyword>adult anaplastic ependymoma</keyword>
	<keyword>adult subependymoma</keyword>
	<keyword>adult medulloblastoma</keyword>
	<keyword>adult supratentorial primitive neuroectodermal tumor ( PNET )</keyword>
	<keyword>adult ependymoblastoma</keyword>
	<keyword>adult ependymoma</keyword>
	<keyword>adult myxopapillary ependymoma</keyword>
	<keyword>adult anaplastic meningioma</keyword>
	<keyword>adult meningeal hemangiopericytoma</keyword>
	<keyword>adult meningioma</keyword>
	<keyword>adult papillary meningioma</keyword>
	<keyword>adult grade I meningioma</keyword>
	<keyword>adult grade II meningioma</keyword>
	<keyword>adult grade III meningioma</keyword>
	<keyword>adult pineal parenchymal tumor</keyword>
	<keyword>recurrent adult brain tumor</keyword>
	<keyword>stage IV pancreatic cancer</keyword>
	<keyword>stage III thymoma</keyword>
	<keyword>stage IVA thymoma</keyword>
	<keyword>stage IVB thymoma</keyword>
</DOC>